The firm will apply the proceeds towards an early-stage clinical trial of a precision colorectal cancer vaccine.
The guidance includes recommendations for extended RAS mutation testing to guide anti-EGFR therapy, as well as updated endorsements for analysis of mismatch repair status.
Copy number changes affecting cancer-related genes appear to be prominent within and across tumors in individuals with colorectal cancer.
The test combines two previously CE marked assays that are based on the company's Nucleosomics platform for identifying and quantifying nucleosome structural features.
The results confirmed that circulating mutations can be reliably detected and changed during treatment, and showed that they could be a valuable prognostic biomarker.
Out of 450 patients with early-onset colorectal cancer, 16 percent carried a known risk mutation for hereditary cancer, including for cancers other than colorectal.
The combination of the new test with Biocartis' existing KRAS assay offers customers a complete solution for testing metastatic colorectal cancers as reccomended by professional guidelines.
Certain alleles at two SNP sites in TP53 coincided with decreased colorectal cancer risk or an earlier time of disease onset in a study of almost 300 Taiwanese individuals with Lynch syndrome.
The company plans to use the proceeds to expand its breast cancer risk test and to develop and commercialize a risk assessment test for colorectal cancer.
The technology involves analyzing susceptibility SNPs in order to predict a patient's likelihood of developing colorectal cancer.
In Science this week: intellectual property landscape of CRISPR genome editing, and more.
A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.
Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.
Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.